DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1031198
Title:
Generation and Characterization of Protective Antibodies to Marburg Virus
Corporate Author:
USAMRIID Frederick United States
Report Date:
2017-04-03
Abstract:
Marburg virus MARV and Ebola virus EBOV have been a source of epidemics and outbreaks for several decades. We present here the generation and characterization of the first protective antibodies specific for wild-type MARV. Non-human primates NHP, cynomolgus macaques, were immunized with viral-replicon particles expressing the glycoproteins GP of MARV Ci67 isolate. An antibody fragment single chain variable fragment, scFv phage display library was built after four immunogen injections, and screened against the GP1-649 of MARV. Sequencing of 192 selected clones identified 18 clones with distinct VH and VL sequences.
Descriptive Note:
Journal Article
Supplementary Note:
Generation and Characterization of Protective Antibodies to Marburg Virus , 01 Jan 0001, 01 Jan 0001,
Pages:
0022
Distribution Statement:
Approved For Public Release;
File Size:
0.92MB